Clinical Trial

Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
As a dietary herb, pueraria lobata radix (PLR) has been showed to have hypoglycemic effects in animal experiments. However, there is currently a lack of evidence from randomized controlled trials. Therefore, this randomized, double-blind, placebo-controlled trial aims to assess the efficacy and safety of PLR as an adjunctive treatment for type 2 diabetes mellitus (T2DM).
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06494683
Lead Sponsor Jiangxi University of Traditional Chinese Medicine
Collaborators: The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, The First Affiliated Hospital of Nanchang University
Conditions Type 2 Diabetes Mellitus
Enrollment 200 participants
Start Date 2024-07-25
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-21